Avadel Pharmaceuticals PLC (NAS:AVDL)
$ 16.25 -1.93 (-10.62%) Market Cap: 3.12 Bil Enterprise Value: 3.02 Bil PE Ratio: 0 PB Ratio: 16.65 GF Score: 44/100

Avadel Pharmaceuticals PLC at Evercore ISI HealthCONx Conference Transcript

Dec 03, 2020 / 02:15PM GMT
Release Date Price: $7 (+2.04%)
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

Fantastic. Listen, guys, thank you, guys, so much for joining us. Pleasure to have Avadel management join us.

Questions & Answers

Umer Raffat;Gregory J. Divis
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research;Avadel Pharmaceuticals plc

Greg, there's a lot to talk about. It seems like there was a point in time where we were talking about the recruiting of your Phase III for narcolepsy with the novel formulation of sodium oxybate. That come -- that's done, you've established that once-nightly works. I think the real question for a lot of investors from here are, not so much about whether your once-nightly works, it's really all about legally and technically when and how fast you can get to market. And there's several and legal regulatory questions that come with that. So I'm going to jump right into it. But first, Greg, when do you expect to file?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot